pLenti6/V5/DEST-VPS35 Citations (4)

Originally described in: GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.
Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L Nature. 2009 Jun 25. 459(7250):1085-90. PubMed Journal

---

Articles Citing pLenti6/V5/DEST-VPS35

Articles
Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin UM, Lees A, Troncoso JC, Lewis PA, Bandopadhyay R, Schneider BL, Moore DJ. Hum Mol Genet. 2014 Sep 1;23(17):4621-38. doi: 10.1093/hmg/ddu178. Epub 2014 Apr 15. PubMed
Parkin mediates the ubiquitination of VPS35 and modulates retromer-dependent endosomal sorting. Williams ET, Glauser L, Tsika E, Jiang H, Islam S, Moore DJ. Hum Mol Genet. 2018 Sep 15;27(18):3189-3205. doi: 10.1093/hmg/ddy224. PubMed
Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Chen X, Kordich JK, Williams ET, Levine N, Cole-Strauss A, Marshall L, Labrie V, Ma J, Lipton JW, Moore DJ. Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5765-5774. doi: 10.1073/pnas.1814909116. Epub 2019 Mar 6. PubMed
Enhanced Hyaluronan Signaling and Autophagy Dysfunction by VPS35 D620N. Rahman AA, Soto-Avellaneda A, Yong Jin H, Stojkovska I, Lai NK, Albright JE, Webb AR, Oe E, Valarde JP, Oxford AE, Urquhart PE, Wagner B, Brown C, Amado I, Vasquez P, Lehning N, Grozdanov V, Pu X, Danzer KM, Morrison BE. Neuroscience. 2020 Aug 10;441:33-45. doi: 10.1016/j.neuroscience.2020.06.009. Epub 2020 Jun 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.